Neuroprotective effect of tafluprost in glaucoma treatment and its molecular mechanism
Journal Title: Eye Science (Yanke Xuebao) - Year 2024, Vol 39, Issue 6
Abstract
Glaucoma is characterized by the progressive degeneration and loss of retinal ganglion cells (RGC) and their axons, making it one of the most common causes of vision loss. Although the exact underlying mechanisms remain unclear, it is well known that elevated intraocular pressure (IOP) is a major risk factor for the progression of glaucoma. Currently, the primary means of controlling glaucoma involves reducing IOP through medication and surgery. Tafluprost, due to its effective and long-term ability to lower IOP, minimal side effects, high patient compliance, and absence of significant systemic side effects, has become the first-line treatment for primary open-angle glaucoma and ocular hypertension. Recent studies suggest that tafluprost may also have neuroprotective effects beyond its IOP-lowering effects. This article aims to review the pharmacological and potential neuroprotective effects of tafluprost, providing a theoretical basis and research foundation for developing more effective drugs for glaucoma treatment. However, there is still a lack of sufficient clinical evidence to support the neuroprotective effects of tafluprost, and further investigations are required to explore in this field to furnish critical theoretical backing for the development of drugs that target optic nerve protection and facilitate vision restoration through optic nerve regeneration.
Authors and Affiliations
Siting WU, Yiqing LI
A modified-simple technique of subluxated lens extraction in children
[Objective:] To investigate the operation method and clinical effects of a modified-simple technique in children with subluxated lens extraction. [Methods:] Lens extraction was performed in 40 eyes of 23 children. During...
Intervention plan for visual field defects in patients with stroke: a scoping review
[Objective:] To systematically analyze the related studies on intervention schemes for patients with visual field defects after stroke, and to identify, summarize, and summarize the specific content, outcome indicators,...
Clinical characteristics and therapeutic effect of 46 cases of bilateral retinoblastoma
[Objective:] To analyze the clinical characteristics and therapeutic effect of 46 patients with bilateral retinoblastoma (RB). [Methods:] The clinical data of 46 patients with bilateral retinoblastoma who received intrav...
Glaucoma secondary to congenital ectropion uveae: case series report and literature review
[Objective:] To analyze the clinical manifestations, imaging characteristics, and treatment methods of secondary glaucoma associated with congenital ectropion uveae (CEU). [Methods:] Observational case series and literat...
Advances in classification, diagnosis and treatment of myopic maculopathy
Myopic maculopathy (MM) is the most common complication of myopia, which is also the main cause of poor visual function in pathologic myopia. Presently, the classification system of MM cannot properly explain the numerou...